ABSTRACT
Silver nanoparticles (AgNPs) can enter eukaryotic cells and exert toxic effects, most probably as a consequence of the release of Ag+ ions. Due to the elusive nature of Ag+ ionic species, quantitative information concerning AgNP intracellular dissolution is missing. By using a synchrotron nanoprobe, silver is visualized and quantified in hepatocytes (HepG2) exposed to AgNPs; the synergistic use of electron microscopy allows for the discrimination between nanoparticular and ionic forms of silver within a single cell. AgNPs are located in endocytosis vesicles, while the visualized Ag+ ions diffuse in the cell. The averaged NP dissolution rates, measured by X-ray absorption spectroscopy, highlight the faster dissolution of citrate-coated AgNPs with respect to the less toxic PVP-coated AgNPs; these results are confirmed at the single-cell level. The released Ag+ ions recombine with thiol-bearing biomolecules: the Ag-S distances measured in cellulo, and the quantitative evaluation of gene expression, provide independent evidence of the involvement of glutathione and metallothioneins in Ag+ binding. The combined use of cutting-edge imaging techniques, atomic spectroscopy and molecular biology brings insight into the fate of AgNPs in hepatocytes, and more generally into the physicochemical transformations of metallic nanoparticles in biological environments and the resulting disruption of metal homeostasis.
Subject(s)
Hepatocytes/metabolism , Metal Nanoparticles , Silver/analysis , Citrates , Hep G2 Cells , Humans , IonsABSTRACT
Germline specific point mutations in the gene encoding fibroblast growth factor receptor 3 (FGFR3) are associated with autosomal dominant human skeletal dysplasia and craniosynostosis syndromes. Mutations identical to the germinal activating mutations found in severe skeletal dysplasias have been identified in certain types of cancer: at low frequency in multiple myeloma and cervix carcinoma and at high frequency in bladder carcinoma. We analysed, by SSCP and sequencing, the prevalence of FGFR3 mutations in 116 primary tumours of various types (upper aerodigestive tract, oesophagus, stomach, lung and skin). The regions analysed encompassed all FGFR3 point mutations previously described in severe skeletal dysplasia and cancers. No mutations were detected in the tumour types examined, suggesting that FGFR3 mutations are restricted to a few tumour types, the evidence to date suggesting that they are very specific to bladder carcinomas.
Subject(s)
Carcinoma/genetics , Receptors, Fibroblast Growth Factor/genetics , Urinary Bladder Neoplasms/genetics , Bone Diseases, Developmental/genetics , Humans , Oncogenes , Point Mutation , Polymorphism, Single-Stranded ConformationalABSTRACT
The effects of hydrocortisone, triamcinolone, prednisolone and dexamethasone have been investigated in vitro using mitochondria isolated from rat brain. Respiratory control ratio (RCR), oxygen consumption, ATP synthesis, enzymatic activities of involved complexes and superoxide anion generation have been measured to assess the effects of these drugs. Our data showed that the decrease of RCR induced by glucocorticoids was due to a common inhibition of oxidative phosphorylation (State 3) and of complex V activity and a modification of the proton-fluxes through the mitochondrial inner membrane. These effects were quantitatively limited, since they occurred at concentrations lower than 2 nM. Dexamethasone was the only one able to induce a specific inhibition of complex I activity and to decrease the superoxide anion radical generation. Inhibition of complex V and partial reversion of uncoupling seem to be common properties of glucocorticoids. The theoretical consequence of these inhibitions could be the modulation of the mitochondrial function, oxygen consumption rate, ATP synthase activity and superoxide anion radical production, involved in many patho-physiological phenomena.
Subject(s)
Brain/drug effects , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Mitochondria/drug effects , Oxygen Consumption/drug effects , Animals , Brain/metabolism , Electron Transport Complex III/metabolism , Hydrocortisone/pharmacology , In Vitro Techniques , Male , Mitochondria/metabolism , Phosphorylation , Prednisolone/pharmacology , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Triamcinolone/pharmacologyABSTRACT
Many image processing problems are ill-posed and must be regularized. Usually, a roughness penalty is imposed on the solution. The difficulty is to avoid the smoothing of edges, which are very important attributes of the image. In this paper, we first give conditions for the design of such an edge-preserving regularization. Under these conditions, we show that it is possible to introduce an auxiliary variable whose role is twofold. First, it marks the discontinuities and ensures their preservation from smoothing. Second, it makes the criterion half-quadratic. The optimization is then easier. We propose a deterministic strategy, based on alternate minimizations on the image and the auxiliary variable. This leads to the definition of an original reconstruction algorithm, called ARTUR. Some theoretical properties of ARTUR are discussed. Experimental results illustrate the behavior of the algorithm. These results are shown in the field of 2D single photon emission tomography, but this method can be applied in a large number of applications in image processing.